Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Total Current Liabilities (2021 - 2025)

Coeptis Therapeutics Holdings has reported Total Current Liabilities over the past 5 years, most recently at $1.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $1.8 million for Q4 2025, down 60.82% from a year ago — trailing twelve months through Dec 2025 was $1.8 million (down 60.82% YoY), and the annual figure for FY2025 was $1.8 million, down 60.82%.
  • Total Current Liabilities for Q4 2025 was $1.8 million at Coeptis Therapeutics Holdings, down from $2.7 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for COEPW hit a ceiling of $5.7 million in Q1 2025 and a floor of $31816.0 in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $2.6 million (2023), compared with a mean of $2.5 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 3976.05% in 2022 and later plummeted 60.82% in 2025.
  • Coeptis Therapeutics Holdings' Total Current Liabilities stood at $2.8 million in 2021, then fell by 21.42% to $2.2 million in 2022, then surged by 37.56% to $3.0 million in 2023, then skyrocketed by 51.01% to $4.5 million in 2024, then plummeted by 60.82% to $1.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $1.8 million (Q4 2025), $2.7 million (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.